Emerging treatment options for the management of Hodgkin's lymphoma: clinical utility of Nivolumab
David A Bond, Lapo Alinari Department of Internal Medicine, Division of Hematology, Arthur G James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, USA Abstract: Classical Hodgkin’s lymphoma (cHL) is a B-cell malignancy comprised of patho...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-05-01
|
| Series: | Journal of Blood Medicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/emerging-treatment-options-for-the-management-of-hodgkins-lymphoma-cl-peer-reviewed-article-JBM |